Atypical Foveal Hypoplasia in Best Disease.
Best disease
OCT-A
fovea plana
foveal avascular zone
foveal hypoplasia
Journal
Journal of personalized medicine
ISSN: 2075-4426
Titre abrégé: J Pers Med
Pays: Switzerland
ID NLM: 101602269
Informations de publication
Date de publication:
15 Feb 2023
15 Feb 2023
Historique:
received:
22
11
2022
revised:
06
02
2023
accepted:
07
02
2023
entrez:
25
2
2023
pubmed:
26
2
2023
medline:
26
2
2023
Statut:
epublish
Résumé
To determine the prevalence and characteristics of foveal hypoplasia (also called fovea plana) in patients with Best disease using spectral-domain (SD) optical coherence tomography (OCT) and OCT-angiography (OCT-A). A retrospective observational study including patients diagnosed with Best disease. Fifty-nine eyes of thirty-two patients (fifteen females (46.9%) and seventeen males (53.1%), Cross-sectional OCT images were assessed for the persistence of inner retinal layers (IRL) and OCT-A was analyzed for the presence of a foveal avascular zone (FAZ), the size of which was determined when applicable. Overall, 16 eyes (27.1%) of 9 patients had a fovea plana appearance ('FP group') with the persistence of IRL, and 43 eyes (72.9%) of 23 patients did not have fovea plana appearance ('no FP group'). Among FP eyes, OCT-A performed in 13 eyes showed bridging vessels through the FAZ in 100% of eyes with OCT-A. Using Thomas classification, 14 out of the 16 eyes with fovea plana (87.5%) had atypical foveal hypoplasia, and the 2 others (12.5%) had a grade 1b fovea plana. In our series, foveal hypoplasia was present in 27.1% of patients with Best disease. OCT-A showed bridging vessels through the FAZ in all eyes. These findings highlight the microvascular changes associated with Best disease, which can be an early sign of the disease in patients with a family history.
Identifiants
pubmed: 36836571
pii: jpm13020337
doi: 10.3390/jpm13020337
pmc: PMC9959407
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Hum Mol Genet. 2018 May 1;27(9):1630-1641
pubmed: 29668979
Ophthalmology. 2011 Aug;118(8):1653-60
pubmed: 21529956
Arch Ophthalmol. 2008 Apr;126(4):507-11
pubmed: 18413520
Retina. 2021 Feb 1;41(2):231-237
pubmed: 33315817
Am J Ophthalmol. 2018 Mar;187:61-70
pubmed: 29288639
Ophthalmol Retina. 2020 Oct;4(10):972
pubmed: 33019989
Br J Ophthalmol. 2022 May;106(5):593-599
pubmed: 33148537
Eur J Hum Genet. 2017 Nov;25(11):1210-1216
pubmed: 28812650
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):4008-13
pubmed: 11904445
Retina. 2015 Nov;35(11):2188-95
pubmed: 26469536
Ophthalmology. 2017 Apr;124(4):456-463
pubmed: 28187978
Doc Ophthalmol. 2017 Feb;134(1):1-9
pubmed: 28110380
J AAPOS. 2014 Oct;18(5):471-5
pubmed: 25266830
Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12758-63
pubmed: 11050159
Nat Genet. 2015 Jul;47(7):757-65
pubmed: 26029869
Turk J Ophthalmol. 2019 Sep 03;49(4):226-229
pubmed: 31486612
Br J Ophthalmol. 2018 Apr;102(4):444-447
pubmed: 28765145
J Curr Ophthalmol. 2019 Jul 16;31(4):442-445
pubmed: 31844798
Eur J Ophthalmol. 2022 Dec 25;:11206721221149067
pubmed: 36567486
Handb Clin Neurol. 2019;160:495-499
pubmed: 31277871
Physiol Rev. 2008 Apr;88(2):639-72
pubmed: 18391176
Indian J Ophthalmol. 2019 Oct;67(10):1733
pubmed: 31546542
Graefes Arch Clin Exp Ophthalmol. 2010 Oct;248(10):1377-86
pubmed: 20414784
Vision Res. 1986;26(6):847-55
pubmed: 3750868
Retina. 2021 Jul 1;41(7):1541-1546
pubmed: 33323906
Arch Ophthalmol. 2008 Jul;126(7):907-13
pubmed: 18625935
Proc Natl Acad Sci U S A. 2021 Sep 28;118(39):
pubmed: 34561305
Ophthalmology. 1984 Jun;91(6):603-12
pubmed: 6462623
Ophthalmology. 2006 Aug;113(8):1392-400
pubmed: 16877078